BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saini D, Weber J, Ramachandran S, Phelan D, Tiriveedhi V, Liu M, Steward N, Aloush A, Hachem R, Trulock E, Meyers B, Patterson GA, Mohanakumar T. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant 2011;30:624-31. [PMID: 21414808 DOI: 10.1016/j.healun.2011.01.708] [Cited by in Crossref: 116] [Cited by in F6Publishing: 104] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Hesemann LE, Subramanian V, Mohanakumar T, Dharnidharka VR. De novo development of antibodies to kidney-associated self-antigens angiotensin II receptor type I, collagen IV, and fibronectin occurs at early time points after kidney transplantation in children. Pediatr Transplant 2015;19:499-503. [PMID: 26058970 DOI: 10.1111/petr.12531] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
2 Kuehnel M, Maegel L, Vogel-Claussen J, Robertus JL, Jonigk D. Airway remodelling in the transplanted lung. Cell Tissue Res 2017;367:663-75. [PMID: 27837271 DOI: 10.1007/s00441-016-2529-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
3 Tissot A, Danger R, Claustre J, Magnan A, Brouard S. Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers. Front Immunol 2019;10:1681. [PMID: 31379869 DOI: 10.3389/fimmu.2019.01681] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
4 Burgel PR, Bergeron A, Knoop C, Dusser D. [Small airway diseases and immune deficiency]. Rev Mal Respir 2016;33:145-55. [PMID: 26854188 DOI: 10.1016/j.rmr.2015.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Gunasekaran M, Maw TT, Santos RD, Shenoy S, Wellen J, Mohanakumar T. Immunoglobulin isotype switching of antibodies to vimentin is associated with development of transplant glomerulopathy following human renal transplantation. Transplant Immunology 2017;45:42-7. [DOI: 10.1016/j.trim.2017.09.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
6 Krenn K, Gmeiner M, Paulus P, Sela N, Torres L, Zins K, Dekan G, Aharinejad S. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans. J Thorac Cardiovasc Surg 2015;149:1194-202. [PMID: 25595376 DOI: 10.1016/j.jtcvs.2014.11.088] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
7 Fernandez IE, Heinzelmann K, Verleden S, Eickelberg O. Characteristic Patterns in the Fibrotic Lung. Comparing Idiopathic Pulmonary Fibrosis with Chronic Lung Allograft Dysfunction. Annals ATS 2015;12:S34-41. [DOI: 10.1513/annalsats.201410-476mg] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Todd JL, Wang X, Sugimoto S, Kennedy VE, Zhang HL, Pavlisko EN, Kelly FL, Huang H, Kreisel D, Palmer SM, Gelman AE. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity. Am J Respir Crit Care Med 2014;189:556-66. [PMID: 24471427 DOI: 10.1164/rccm.201308-1481OC] [Cited by in Crossref: 65] [Cited by in F6Publishing: 39] [Article Influence: 8.1] [Reference Citation Analysis]
9 Dieudé M, Turgeon J, Karakeussian Rimbaud A, Beillevaire D, Qi S, Patey N, Gaboury LA, Boilard É, Hébert MJ. Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts. Am J Transplant 2020;20:726-38. [PMID: 31729155 DOI: 10.1111/ajt.15707] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
10 Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013;95:19-47. [PMID: 23238534 DOI: 10.1097/tp.0b013e31827a19cc] [Cited by in Crossref: 525] [Cited by in F6Publishing: 144] [Article Influence: 58.3] [Reference Citation Analysis]
11 Schonewille H, van de Watering LMG, Oepkes D, Lopriore E, Cobbaert CM, Brand A. Prevalence of red-blood-cell and non-red-blood-cell-targeted autoantibodies in alloimmunized postpartum women. Vox Sang 2020;115:783-9. [PMID: 32458481 DOI: 10.1111/vox.12941] [Reference Citation Analysis]
12 Zhang Q, Reed EF. The importance of non-HLA antibodies in transplantation. Nat Rev Nephrol 2016;12:484-95. [PMID: 27345243 DOI: 10.1038/nrneph.2016.88] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 14.2] [Reference Citation Analysis]
13 Pinelli DF, Friedewald JJ, Haarberg KMK, Radhakrishnan SL, Zitzner JR, Hanshew WE, Tambur AR. Assessing the potential of angiotensin II type 1 receptor and donor specific anti-endothelial cell antibodies to predict long-term kidney graft outcome. Hum Immunol 2017;78:421-7. [PMID: 28372986 DOI: 10.1016/j.humimm.2017.03.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
14 Kaza V, Zhu C, Terada LS, Wang L, Torres F, Bollineni S, Mohanka M, Banga A, Joerns J, Mohanakumar T, Li QZ. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction. Hum Immunol 2021;82:25-35. [PMID: 33129576 DOI: 10.1016/j.humimm.2020.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Abadja F, Sarraj B, Ansari MJ. Significance of T helper 17 immunity in transplantation. Curr Opin Organ Transplant 2012;17:8-14. [PMID: 22186097 DOI: 10.1097/MOT.0b013e32834ef4e4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
16 Bharat A, Mohanakumar T. Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection. J Immunol Res 2017;2017:6312514. [PMID: 28164137 DOI: 10.1155/2017/6312514] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
17 Verleden SE, Sacreas A, Vos R, Vanaudenaerde BM, Verleden GM. Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation. Chest 2016;150:219-25. [PMID: 27212132 DOI: 10.1016/j.chest.2016.04.014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
18 Sweet SC. Community-Acquired Respiratory Viruses Post-Lung Transplant. Semin Respir Crit Care Med 2021;42:449-59. [PMID: 34030206 DOI: 10.1055/s-0041-1729172] [Reference Citation Analysis]
19 Weber J, Tiriveedhi V, Takenaka M, Lu W, Hachem R, Trulock E, Patterson GA, Mohanakumar T. Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-α-dependant interleukin-17. J Heart Lung Transplant 2012;31:419-26. [PMID: 22289485 DOI: 10.1016/j.healun.2011.12.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
20 Aguilar PR, Michelson AP, Isakow W. Obliterative Bronchiolitis. Transplantation 2016;100:272-83. [DOI: 10.1097/tp.0000000000000892] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
21 Patel KJ, Cheng Q, Stephenson S, Allen DP, Li C, Kilkenny J, Finnegan R, Montalvo-Calero V, Esckilsen S, Vasu C, Goddard M, Nadig SN, Atkinson C. Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury. Am J Respir Cell Mol Biol 2019;60:678-86. [PMID: 30571141 DOI: 10.1165/rcmb.2018-0224OC] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
22 Budding K, van de Graaf EA, Kardol-Hoefnagel T, Oudijk ED, Kwakkel-van Erp JM, Hack CE, Otten HG. Antibodies against Apoptotic Cells Present in End-stage Lung Disease Patients Do Not Correlate with Clinical Outcome after Lung Transplantation. Front Immunol 2017;8:322. [PMID: 28377770 DOI: 10.3389/fimmu.2017.00322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Shah P, Tang D, Shah K, Mehra MR. JHLT highlights 2011: cardiothoracic transplantation, pulmonary hypertension, and mechanical circulatory support. J Heart Lung Transplant 2012;31:1257-61. [PMID: 23206983 DOI: 10.1016/j.healun.2012.09.028] [Reference Citation Analysis]
24 Kardol-Hoefnagel T, Otten HG. A Comprehensive Overview of the Clinical Relevance and Treatment Options for Antibody-mediated Rejection Associated With Non-HLA Antibodies. Transplantation 2021;105:1459-70. [PMID: 33208690 DOI: 10.1097/TP.0000000000003551] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bansal S, McGilvrey M, Garcia-Mansfield K, Sharma R, Bremner RM, Smith MA, Hachem R, Pirrotte P, Mohanakumar T. Global Proteomics Analysis of Circulating Extracellular Vesicles Isolated from Lung Transplant Recipients. ACS Omega 2020;5:14360-9. [PMID: 32596573 DOI: 10.1021/acsomega.0c00859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Hachem RR. The impact of non-HLA antibodies on outcomes after lung transplantation and implications for therapeutic approaches. Hum Immunol 2019;80:583-7. [PMID: 31005400 DOI: 10.1016/j.humimm.2019.04.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Mansell H, Soliman M, Elmoselhi H, Shoker A. Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events. PLoS One 2015;10:e0142141. [PMID: 26544186 DOI: 10.1371/journal.pone.0142141] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
28 Akbarpour M, Wu Q, Liu X, Sun H, Lecuona E, Tomic R, Bhorade S, Mohanakumar T, Bharat A. Clinical relevance of lung-restricted antibodies in lung transplantation. Hum Immunol 2019;80:595-601. [PMID: 31078336 DOI: 10.1016/j.humimm.2019.04.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
29 Amubieya O, Ramsey A, DerHovanessian A, Fishbein GA, Lynch JP 3rd, Belperio JA, Weigt SS. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies. Semin Respir Crit Care Med 2021;42:392-410. [PMID: 34030202 DOI: 10.1055/s-0041-1729175] [Reference Citation Analysis]
30 Tiriveedhi V, Gautam B, Sarma NJ, Askar M, Budev M, Aloush A, Hachem R, Trulock E, Myers B, Patterson AG, Mohanakumar T. Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations. J Heart Lung Transplant 2013;32:807-14. [PMID: 23856218 DOI: 10.1016/j.healun.2013.06.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 6.1] [Reference Citation Analysis]
31 Akbarpour M, Bharat A. Lung Injury and Loss of Regulatory T Cells Primes for Lung-Restricted Autoimmunity. Crit Rev Immunol 2017;37:23-37. [PMID: 29431077 DOI: 10.1615/CritRevImmunol.2017024944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Werlein C, Seidel A, Warnecke G, Gottlieb J, Laenger F, Jonigk D. Lung Transplant Pathology: An Overview on Current Entities and Procedures. Surg Pathol Clin 2020;13:119-40. [PMID: 32005428 DOI: 10.1016/j.path.2019.11.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Sommerwerck U, Rabis T, Fleimisch P, Carstens H, Teschler H, Kamler M. [Lung transplantation]. Herz 2014;39:74-83. [PMID: 24477632 DOI: 10.1007/s00059-013-4044-3] [Reference Citation Analysis]
34 Emtiazjoo AM, Wilkes DS. Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link? Am J Respir Cell Mol Biol 2013;48:145-9. [PMID: 23087052 DOI: 10.1165/rcmb.2012-0349RT] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
35 Dieudé M, Bell C, Turgeon J, Beillevaire D, Pomerleau L, Yang B, Hamelin K, Qi S, Pallet N, Béland C, Dhahri W, Cailhier J, Rousseau M, Duchez A, Lévesque T, Lau A, Rondeau C, Gingras D, Muruve D, Rivard A, Cardinal H, Perreault C, Desjardins M, Boilard É, Thibault P, Hébert M. The 20 S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection. Sci Transl Med 2015;7:318ra200-318ra200. [DOI: 10.1126/scitranslmed.aac9816] [Cited by in Crossref: 90] [Cited by in F6Publishing: 90] [Article Influence: 12.9] [Reference Citation Analysis]
36 Naikawadi RP, Green G, Jones KD, Achtar-Zadeh N, Mieleszko JE, Arnould I, Kukreja J, Greenland JR, Wolters PJ. Airway Epithelial Telomere Dysfunction Drives Remodeling Similar to Chronic Lung Allograft Dysfunction. Am J Respir Cell Mol Biol 2020;63:490-501. [PMID: 32551854 DOI: 10.1165/rcmb.2019-0374OC] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Ranganathan S, Zeevi A, Ozolek J, Venkat V, Soltys K, Mazariegos G, Sindhi R. Autoimmunity, alloimmunity, and chronic liver allograft injury. Pediatr Transplant 2012;16:402-3. [PMID: 22694260 DOI: 10.1111/j.1399-3046.2012.01757.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Paul P, Pedini P, Lyonnet L, Di Cristofaro J, Loundou A, Pelardy M, Basire A, Dignat-George F, Chiaroni J, Thomas P, Reynaud-Gaubert M, Picard C. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant. Front Immunol 2019;10:1208. [PMID: 31249568 DOI: 10.3389/fimmu.2019.01208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
39 Slavcev A. Prediction of organ transplant rejection by HLA-specific and non-HLA antibodies - brief literature review. Int J Immunogenet 2013;40:83-7. [DOI: 10.1111/j.1744-313x.2012.01139.x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
40 Weigt SS, DerHovanessian A, Wallace WD, Lynch JP 3rd, Belperio JA. Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation. Semin Respir Crit Care Med 2013;34:336-51. [PMID: 23821508 DOI: 10.1055/s-0033-1348467] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 7.7] [Reference Citation Analysis]
41 Seifert ME, Gunasekaran M, Horwedel TA, Daloul R, Storch GA, Mohanakumar T, Brennan DC. Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation. J Am Soc Nephrol 2017;28:1314-25. [PMID: 27821629 DOI: 10.1681/ASN.2016030285] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
42 Gunasekaran M, Sharma M, Hachem R, Bremner R, Smith MA, Mohanakumar T. Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection. J Immunol. 2018;200:2535-2541. [PMID: 29491008 DOI: 10.4049/jimmunol.1701587] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
43 Delville M, Charreau B, Rabant M, Legendre C, Anglicheau D. Pathogenesis of non-HLA antibodies in solid organ transplantation: Where do we stand? Hum Immunol 2016;77:1055-62. [PMID: 27237040 DOI: 10.1016/j.humimm.2016.05.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
44 Tiriveedhi V, Sarma N, Mohanakumar T. An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection. Int J Immunogenet 2012;39:373-80. [PMID: 22486939 DOI: 10.1111/j.1744-313X.2012.01112.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
45 Chong AS, Alegre ML. The impact of infection and tissue damage in solid-organ transplantation. Nat Rev Immunol. 2012;12:459-471. [PMID: 22627862 DOI: 10.1038/nri3215] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 9.1] [Reference Citation Analysis]
46 Reinsmoen NL. Compelling scientific and clinical evidence that non-HLA specific antibodies impact graft outcome independently and in concert with donor HLA specific antibodies. Hum Immunol 2019;80:555-60. [PMID: 31279533 DOI: 10.1016/j.humimm.2019.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
47 Foster MH. Basement membranes and autoimmune diseases. Matrix Biol 2017;57-58:149-68. [PMID: 27496347 DOI: 10.1016/j.matbio.2016.07.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
48 Scallan C, Venado A, Han L, Xu H, Mulligan M, Raghu G. Recurrent Pulmonary Fibrosis in a Lung Allograft Secondary to De Novo Antisynthetase Syndrome. Ann Am Thorac Soc 2020;17:901-4. [PMID: 32437253 DOI: 10.1513/AnnalsATS.202002-126RL] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Meyer KC. Lung transplantation. F1000Prime Rep 2013;5:16. [PMID: 23710330 DOI: 10.12703/P5-16] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
50 Itabashi Y, Ravichandran R, Bansal S, Bharat A, Hachem R, Bremner R, Smith M, Mohanakumar T. Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation. Transplantation 2021;105:1337-46. [PMID: 32890135 DOI: 10.1097/TP.0000000000003428] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Arjuna A, Olson MT, Walia R, Bremner RM, Smith MA, Mohanakumar T. An update on current treatment strategies for managing bronchiolitis obliterans syndrome after lung transplantation. Expert Rev Respir Med 2021;15:339-50. [PMID: 33054424 DOI: 10.1080/17476348.2021.1835475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Piotti G, Palmisano A, Maggiore U, Buzio C. Vascular endothelium as a target of immune response in renal transplant rejection. Front Immunol. 2014;5:505. [PMID: 25374567 DOI: 10.3389/fimmu.2014.00505] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
53 Suzuki H, Lasbury ME, Fan L, Vittal R, Mickler EA, Benson HL, Shilling R, Wu Q, Weber DJ, Wagner SR. Role of complement activation in obliterative bronchiolitis post-lung transplantation. J Immunol. 2013;191:4431-4439. [PMID: 24043901 DOI: 10.4049/jimmunol.1202242] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
54 Nayak DK, Saravanan PB, Bansal S, Naziruddin B, Mohanakumar T. Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation. Front Immunol 2016;7:650. [PMID: 28066448 DOI: 10.3389/fimmu.2016.00650] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
55 Tiriveedhi V, Takenaka M, Sarma NJ, Gelman AG, Mohanakumar T. Anti-major histocompatibility complex-induced obliterative airway disease: selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens. J Heart Lung Transplant 2013;32:714-22. [PMID: 23643508 DOI: 10.1016/j.healun.2013.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
56 Gunasekaran M, Xu Z, Nayak DK, Sharma M, Hachem R, Walia R, Bremner RM, Smith MA, Mohanakumar T. Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection. Am J Transplant. 2017;17:474-484. [PMID: 27278097 DOI: 10.1111/ajt.13915] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 9.7] [Reference Citation Analysis]
57 Royer P, Olivera-botello G, Koutsokera A, Aubert J, Bernasconi E, Tissot A, Pison C, Nicod L, Boissel J, Magnan A. Chronic Lung Allograft Dysfunction: A Systematic Review of Mechanisms. Transplantation 2016;100:1803-14. [DOI: 10.1097/tp.0000000000001215] [Cited by in Crossref: 51] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
58 Kulkarni HS, Tsui K, Sunder S, Ganninger A, Tague LK, Witt CA, Byers DE, Trulock EP, Nava R, Puri V, Kreisel D, Mohanakumar T, Gelman AE, Hachem RR. Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation. Am J Transplant 2020;20:1028-38. [PMID: 31677358 DOI: 10.1111/ajt.15687] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
59 Rao U, Sharma M, Mohanakumar T, Ahn C, Gao A, Kaza V. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience. Transpl Immunol 2019;54:65-72. [PMID: 30794945 DOI: 10.1016/j.trim.2019.02.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
60 Agashe VV, Burlingham WJ. Autoimmune Reactivity in Graft Injury: Player or Bystander? Curr Transplant Rep 2015;2:211-21. [PMID: 29057202 DOI: 10.1007/s40472-015-0068-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
61 Vittal R, Fan L, Greenspan DS, Mickler EA, Gopalakrishnan B, Gu H, Benson HL, Zhang C, Burlingham W, Cummings OW, Wilkes DS. IL-17 induces type V collagen overexpression and EMT via TGF-β-dependent pathways in obliterative bronchiolitis. Am J Physiol Lung Cell Mol Physiol 2013;304:L401-14. [PMID: 23262228 DOI: 10.1152/ajplung.00080.2012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
62 Bansal S, Arjuna A, Perincheri S, Poulson C, Bremner RM, Smith MA, Tokman S, Mohanakumar T. Restrictive allograft syndrome vs bronchiolitis obliterans syndrome: Immunological and molecular characterization of circulating exosomes. J Heart Lung Transplant 2021:S1053-2498(21)02487-6. [PMID: 34602310 DOI: 10.1016/j.healun.2021.09.001] [Reference Citation Analysis]
63 Valenzuela NM, McNamara JT, Reed EF. Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. Curr Opin Organ Transplant. 2014;19:33-40. [PMID: 24316758 DOI: 10.1097/mot.0000000000000040] [Cited by in Crossref: 69] [Cited by in F6Publishing: 32] [Article Influence: 8.6] [Reference Citation Analysis]
64 Nayak DK, Zhou F, Xu M, Huang J, Tsuji M, Hachem R, Mohanakumar T. Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses. Am J Transplant 2016;16:2300-11. [PMID: 27062199 DOI: 10.1111/ajt.13819] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 10.5] [Reference Citation Analysis]
65 Lama VN, Belperio JA, Christie JD, El-Chemaly S, Fishbein MC, Gelman AE, Hancock WW, Keshavjee S, Kreisel D, Laubach VE, Looney MR, McDyer JF, Mohanakumar T, Shilling RA, Panoskaltsis-Mortari A, Wilkes DS, Eu JP, Nicolls MR. Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop. JCI Insight 2017;2:93121. [PMID: 28469087 DOI: 10.1172/jci.insight.93121] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
66 Angaswamy N, Tiriveedhi V, Sarma NJ, Subramanian V, Klein C, Wellen J, Shenoy S, Chapman WC, Mohanakumar T. Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection. Hum Immunol 2013;74:1478-85. [PMID: 23876679 DOI: 10.1016/j.humimm.2013.07.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
67 Gunasekaran M, Vachharajani N, Gaut JP, Maw TT, Delos Santos R, Shenoy S, Chapman WC, Wellen J, Mohanakumar T. Development of immune response to tissue-restricted self-antigens in simultaneous kidney-pancreas transplant recipients with acute rejection. Clin Transplant 2017;31. [PMID: 28639386 DOI: 10.1111/ctr.13009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
68 Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, Brozek J, Glanville AR. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur Respir J. 2014;44:1479-1503. [PMID: 25359357 DOI: 10.1183/09031936.00107514] [Cited by in Crossref: 308] [Cited by in F6Publishing: 276] [Article Influence: 38.5] [Reference Citation Analysis]
69 Hachem RR, Tiriveedhi V, Patterson GA, Aloush A, Trulock EP, Mohanakumar T. Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant 2012;12:2164-71. [PMID: 22568593 DOI: 10.1111/j.1600-6143.2012.04079.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 101] [Article Influence: 10.8] [Reference Citation Analysis]
70 Baskaran G, Tiriveedhi V, Ramachandran S, Aloush A, Grossman B, Hachem R, Mohanakumar T. Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients. J Heart Lung Transplant 2014;33:950-6. [PMID: 24906794 DOI: 10.1016/j.healun.2014.04.020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
71 van der Ploeg EA, Melgert BN, Burgess JK, Gan CT. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction. Transplant Rev (Orlando) 2021;35:100626. [PMID: 33992914 DOI: 10.1016/j.trre.2021.100626] [Reference Citation Analysis]
72 Campbell P. Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation. Curr Opin Organ Transplant. 2013;18:463-469. [PMID: 23838652 DOI: 10.1097/mot.0b013e3283636c71] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
73 Takenaka M, Subramanian V, Tiriveedhi V, Phelan D, Hachem R, Trulock E, Gelman AE, Patterson GA, Hoshinaga K, Mohanakumar T. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection. J Heart Lung Transplant 2012;31:1214-22. [PMID: 22980951 DOI: 10.1016/j.healun.2012.08.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
74 Tiriveedhi V, Takenaka M, Ramachandran S, Gelman AE, Subramanian V, Patterson GA, Mohanakumar T. T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease. Am J Transplant 2012;12:2663-74. [PMID: 22822907 DOI: 10.1111/j.1600-6143.2012.04191.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
75 Ravichandran R, Bansal S, Rahman M, Sharma M, Liu W, Bharat A, Hachem R, Omar A, Smith MA, Mohanakumar T. The role of donor-derived exosomes in lung allograft rejection. Hum Immunol 2019;80:588-94. [PMID: 30898684 DOI: 10.1016/j.humimm.2019.03.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
76 Zorn E, See SB. Is There a Role for Natural Antibodies in Rejection Following Transplantation? Transplantation 2019;103:1612-9. [PMID: 30951015 DOI: 10.1097/TP.0000000000002743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
77 Sarma NJ, Tiriveedhi V, Angaswamy N, Mohanakumar T. Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications. Hum Immunol 2012;73:1275-81. [PMID: 22789626 DOI: 10.1016/j.humimm.2012.06.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
78 Angaswamy N, Klein C, Tiriveedhi V, Gaut J, Anwar S, Rossi A, Phelan D, Wellen JR, Shenoy S, Chapman WC, Mohanakumar T. Immune responses to collagen-IV and fibronectin in renal transplant recipients with transplant glomerulopathy. Am J Transplant 2014;14:685-93. [PMID: 24410875 DOI: 10.1111/ajt.12592] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
79 Shtraichman O, Diamond JM. Emerging biomarkers in chronic lung allograft dysfunction. Expert Rev Mol Diagn 2020;20:467-75. [PMID: 32133875 DOI: 10.1080/14737159.2020.1738929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Basha HI, Ramachandran S, Tiriveedhi V, Takenaka M, Subramanian V, Nath DS, Benshoff N, Patterson GA, Mohanakumar T. Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies. Transplantation 2013;95:293-300. [PMID: 23325004 DOI: 10.1097/TP.0b013e3182772244] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
81 Islam AK, Sinha N, DeVos JM, Kaleekal TS, Jyothula SS, Teeter LD, Nguyen DTM, Eagar TN, Moore LW, Puppala M, Wong STC, Knight RJ, Frost AE, Graviss EA, Osama Gaber A. Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation. Clin Transplant 2017;31. [PMID: 28658512 DOI: 10.1111/ctr.13028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
82 Frye CC, Bery AI, Kreisel D, Kulkarni HS. Sterile inflammation in thoracic transplantation. Cell Mol Life Sci 2021;78:581-601. [PMID: 32803398 DOI: 10.1007/s00018-020-03615-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Subramanian V, Mohanakumar T. Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens. Expert Rev Clin Immunol 2012;8:663-72. [PMID: 23078063 DOI: 10.1586/eci.12.58] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
84 Ius F, Sommer W, Tudorache I, Kühn C, Avsar M, Siemeni T, Salman J, Hallensleben M, Kieneke D, Greer M, Gottlieb J, Haverich A, Warnecke G. Early donor-specific antibodies in lung transplantation: risk factors and impact on survival. J Heart Lung Transplant 2014;33:1255-63. [PMID: 25070908 DOI: 10.1016/j.healun.2014.06.015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 5.5] [Reference Citation Analysis]
85 Sarma NJ, Tiriveedhi V, Mohanakumar T. Detection of antibodies to self-antigens (K-alpha 1 tubulin, collagen I, II, IV, and V, myosin, and vimentin) by enzyme-linked immunosorbent assay (ELISA). Methods Mol Biol 2013;1034:335-41. [PMID: 23775748 DOI: 10.1007/978-1-62703-493-7_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
86 Gunasekaran M, Bansal S, Ravichandran R, Sharma M, Perincheri S, Rodriguez F, Hachem R, Fisher CE, Limaye AP, Omar A, Smith MA, Bremner RM, Mohanakumar T. Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection. J Heart Lung Transplant 2020;39:379-88. [PMID: 32033844 DOI: 10.1016/j.healun.2019.12.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
87 Obregon C, Graf L, Chung KF, Cesson V, Nicod LP. Nitric oxide sustains IL-1β expression in human dendritic cells enhancing their capacity to induce IL-17-producing T-cells. PLoS One 2015;10:e0120134. [PMID: 25853810 DOI: 10.1371/journal.pone.0120134] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
88 Kalache S, Lakhani P, Heeger PS. Effects of preexisting autoimmunity on heart graft prolongation after donor-specific transfusion and anti-CD154. Transplantation 2014;97:12-9. [PMID: 24056628 DOI: 10.1097/TP.0b013e3182a77eba] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
89 Nayak DK, Zhou F, Xu M, Huang J, Tsuji M, Yu J, Hachem R, Gelman AE, Bremner RM, Smith MA, Mohanakumar T. Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection. Sci Transl Med 2017;9:eaal1243. [PMID: 28701473 DOI: 10.1126/scitranslmed.aal1243] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
90 Anglicheau D, Delville M, Lamarthee B. Non anti-HLA antibodies and acute rejection: A critical viewpoint. Nephrol Ther 2019;15 Suppl 1:S53-9. [PMID: 30981396 DOI: 10.1016/j.nephro.2019.03.003] [Reference Citation Analysis]
91 Dieudé M, Kaci I, Hébert MJ. The Impact of Programmed Cell Death on the Formation of Tertiary Lymphoid Structures. Front Immunol 2021;12:696311. [PMID: 34335608 DOI: 10.3389/fimmu.2021.696311] [Reference Citation Analysis]
92 Glanville AR. Why does the transplanted lung sometimes fail to work? Am J Respir Crit Care Med 2013;187:462-4. [PMID: 23457364 DOI: 10.1164/rccm.201212-2335ED] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
93 Claustre J, Quétant S, Camara B, France M, Schummer G, Bedouch P, Pavese P, Raymond CS, Bardy B, Masson D, Roth H, Pison C. Nonspecific Immunoglobulin Replacement in Lung Transplantation Recipients With Hypogammaglobulinemia: A Cohort Study Taking Into Account Propensity Score and Immortal Time Bias. Transplantation 2015;99:444-50. [DOI: 10.1097/tp.0000000000000339] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
94 Gracon AS, Wilkes DS. Lung transplantation: chronic allograft dysfunction and establishing immune tolerance. Hum Immunol 2014;75:887-94. [PMID: 24979671 DOI: 10.1016/j.humimm.2014.06.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
95 Chiu S, Fernandez R, Subramanian V, Sun H, DeCamp MM, Kreisel D, Perlman H, Budinger GR, Mohanakumar T, Bharat A. Lung Injury Combined with Loss of Regulatory T Cells Leads to De Novo Lung-Restricted Autoimmunity. J Immunol 2016;197:51-7. [PMID: 27194786 DOI: 10.4049/jimmunol.1502539] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
96 Sureshbabu A, Fleming T, Mohanakumar T. Autoantibodies in lung transplantation. Transpl Int 2020;33:41-9. [PMID: 31393646 DOI: 10.1111/tri.13487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
97 Lin CM, Zamora MR. Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation. Curr Transplant Rep 2014;1:282-9. [PMID: 32226712 DOI: 10.1007/s40472-014-0030-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Bharat A, Chiu S, Zheng Z, Sun H, Yeldandi A, DeCamp MM, Perlman H, Budinger GR, Mohanakumar T. Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation. Am J Respir Cell Mol Biol 2016;55:532-41. [PMID: 27144500 DOI: 10.1165/rcmb.2016-0077OC] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
99 Xu Z, Nayak DK, Benshoff N, Hachem R, Gelman AE, Mohanakumar T. De novo-developed antibodies to donor MHC antigens lead to dysregulation of microRNAs and induction of MHC class II. J Immunol 2015;194:6133-43. [PMID: 25941328 DOI: 10.4049/jimmunol.1401848] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
100 Gill RG, Burrack AL. Diverse Routes of Allograft Tolerance Disruption by Memory T Cells. Front Immunol 2020;11:580483. [PMID: 33117387 DOI: 10.3389/fimmu.2020.580483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Liu Z, Fan H, Jiang S. CD4 + T-cell subsets in transplantation. Immunol Rev 2013;252:183-91. [DOI: 10.1111/imr.12038] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]
102 Yung GL, Craig V. Lung transplantation and extracorporeal photopheresis: The answer to bronchiolitis obliterans? Transfusion and Apheresis Science 2015;52:162-6. [DOI: 10.1016/j.transci.2015.02.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
103 Mengel M, Husain S, Hidalgo L, Sis B. Phenotypes of antibody-mediated rejection in organ transplants: Antibody-mediated rejection. Transplant International 2012;25:611-22. [DOI: 10.1111/j.1432-2277.2012.01484.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
104 Le Pavec J, Suberbielle C, Lamrani L, Feuillet S, Savale L, Dorfmüller P, Stephan F, Mussot S, Mercier O, Fadel E. De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome. J Heart Lung Transplant 2016;35:1067-77. [PMID: 27373824 DOI: 10.1016/j.healun.2016.05.020] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
105 Subramanian V, Ramachandran S, Banan B, Bharat A, Wang X, Benshoff N, Kreisel D, Gelman AE, Mohanakumar T. Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation. Am J Transplant 2014;14:2359-66. [PMID: 25220332 DOI: 10.1111/ajt.12908] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
106 Takenaka M, Tiriveedhi V, Subramanian V, Hoshinaga K, Patterson AG, Mohanakumar T. Antibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease. PLoS One 2012;7:e42370. [PMID: 22900015 DOI: 10.1371/journal.pone.0042370] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
107 Butler CL, Valenzuela NM, Thomas KA, Reed EF. Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection. J Immunol Res 2017;2017:7903471. [PMID: 28373996 DOI: 10.1155/2017/7903471] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]